Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
SNES 
SenesTech Inc (SNES)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: SNES (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -57.26% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.30M USD | Price to earnings Ratio - | 1Y Target Price 10 |
Price to earnings Ratio - | 1Y Target Price 10 | ||
Volume (30-day avg) 182122 | Beta 0.1 | 52 Weeks Range 1.74 - 9.80 | Updated Date 04/1/2025 |
52 Weeks Range 1.74 - 9.80 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -8.86 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -250.9% |
Management Effectiveness
Return on Assets (TTM) -73.89% | Return on Equity (TTM) -139.56% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 2099474 | Price to Sales(TTM) 1.78 |
Enterprise Value 2099474 | Price to Sales(TTM) 1.78 | ||
Enterprise Value to Revenue 1.13 | Enterprise Value to EBITDA 0.11 | Shares Outstanding 1746930 | Shares Floating 1686242 |
Shares Outstanding 1746930 | Shares Floating 1686242 | ||
Percent Insiders 3.47 | Percent Institutions 7.41 |
Analyst Ratings
Rating 4 | Target Price 10 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
SenesTech Inc
Company Overview
History and Background
SenesTech, Inc. was founded in 2004. It focuses on developing and commercializing technologies for managing animal pest populations through fertility control. They initially targeted rats, but the business model has struggled.
Core Business Areas
- Pest Management: SenesTech develops and commercializes products designed to control pest populations by reducing fertility, primarily targeting rats with ContraPest. This business also offers services for pest management in areas.
Leadership and Structure
The leadership team includes individuals in executive roles such as CEO, CFO, and Chief Scientific Officer. SenesTech operates with a board of directors and functional departments covering sales, marketing, research, and operations.
Top Products and Market Share
Key Offerings
- ContraPest: ContraPest is SenesTech's primary product, a liquid bait designed to reduce rat fertility. Market share data is limited and difficult to ascertain precisely due to the fragmented nature of the pest control market and varying reporting methods. Competitors include traditional rodenticides and integrated pest management solutions from companies like Rollins (ROL) and Ecolab (ECL).
Market Dynamics
Industry Overview
The pest control industry is large and growing, driven by urbanization, climate change, and increased awareness of public health concerns. The market is comprised of companies that specialize in various different solutions from physical traps, integrated solutions and chemical solutions.
Positioning
SenesTech aims to differentiate itself by offering a non-lethal and eco-friendly approach to pest control. Their competitive advantage lies in addressing rat fertility rather than directly killing the pests.
Total Addressable Market (TAM)
The global pest control market is estimated to be over $20 billion annually. SenesTech's positioning allows them to capture a portion of this market. This is only possible if they scale up production and sales effectively and prove efficacy in large-scale deployments.
Upturn SWOT Analysis
Strengths
- Non-lethal approach appealing to environmentally conscious customers
- Proprietary fertility control technology
- Potential for use in diverse settings (agriculture, urban areas, etc.)
Weaknesses
- Limited market penetration
- High operational costs
- Dependence on a single product
- Limited financial resources
- Inconsistent sales execution and turnover
Opportunities
- Expanding into new geographic markets
- Developing new applications for fertility control technology
- Partnering with pest control service providers
- Increasing regulatory acceptance of fertility control methods
Threats
- Competition from established pest control companies
- Regulatory hurdles
- Resistance from pest populations
- Fluctuations in commodity prices (e.g., bait ingredients)
Competitors and Market Share
Key Competitors
- ROL
- ECL
Competitive Landscape
SenesTech faces a challenging competitive landscape with established players in the industry that have greater resources and established distribution networks. SenesTech needs to show it can scale while maintaining efficacy.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been slow and inconsistent.
Future Projections: Analyst projections are limited and highly speculative given the company's volatile performance.
Recent Initiatives: SenesTech has been focusing on streamlining operations and seeking new partnerships.
Summary
SenesTech faces significant challenges, including limited market penetration, dependence on one product, and substantial financial constraints. While its eco-friendly approach offers a potential advantage, effectively scaling production and sales with financial resources is imperative for future success. The company's success hinges on overcoming competition, securing partnerships, and realizing efficacy and scalability for its product.
Similar Companies
- ROL
- ECL
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Industry Reports
- Financial News Sources
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a financial professional. Market share estimates are based on available data and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SenesTech Inc
Exchange NASDAQ | Headquaters Phoenix, AZ, United States | ||
IPO Launch date 2016-12-08 | CEO, President & Director Mr. Joel L. Fruendt | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 23 | Website https://www.senestech.com |
Full time employees 23 | Website https://www.senestech.com | ||
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.